Concepedia

Busen Wang

BW

16

Publications

3.7K

Citations

13

H-Index

2017

Active since

Affiliations

CanSino (China)(Current)

Academy of Military Medical Sciences

Institute of Microbiology

Jiangsu Provincial Center for Disease Control and Prevention

Wuhan University

Busen Wang is an author at CanSino (China) specializing in immunology, medicine, and vaccination.

ORCID

Top concepts

Publications per year

2017–2023

16

Publications

16

Safety, tolerability, and immunogenicity of a recombinant adenovirus type-5 vectored COVID-19 vaccine: a dose-escalation, open-label, non-randomised, first-in-human trial

Fengcai Zhu, Yu-Hua Li, Xu-Hua Guan et al. · The Lancet · 2020 · 1.4K citations · Full text

Immunogenicity and safety of a recombinant adenovirus type-5-vectored COVID-19 vaccine in healthy adults aged 18 years or older: a randomised, double-blind, placebo-controlled, phase 2 trial

Fengcai Zhu, Xu-Hua Guan, Yu-Hua Li et al. · The Lancet · 2020 · 1.3K citations · Full text

Safety, tolerability, and immunogenicity of an aerosolised adenovirus type-5 vector-based COVID-19 vaccine (Ad5-nCoV) in adults: preliminary report of an open-label and randomised phase 1 clinical trial

Shipo Wu, Jianying Huang, Zhe Zhang et al. · The Lancet Infectious Diseases · 2021 · 291 citations · Full text

A single dose of an adenovirus-vectored vaccine provides protection against SARS-CoV-2 challenge

Shipo Wu, Gongxun Zhong, Jun Zhang et al. · Nature Communications · 2020 · 284 citations · Full text

Seroepidemiological investigation of HAdV-4 infection among healthy adults in China and in Sierra Leone, West Africa

Busen Wang, Jianhua Li, Shipo Wu et al. · Emerging Microbes & Infections · 2018 · 116 citations · Full text

, , +13

Rows per page

1–5 of 16